RISK Factors | Total Patients N = 100 | P value | Odds Ratio | Confidence Interval | |||
---|---|---|---|---|---|---|---|
No of patients | Patients with CPE (n = 26) (%) | Patients without CPE (n = 74) (%) | |||||
Sex (Male) | 58 | 17 (65.3) | 41 (55.4) | 0.37 | 1.52 | 0.600 | 3.849 |
Antibiotics use | |||||||
Carbapenems | 14 | 7 (26.9) | 7 (9.5) | 0.027 | 3.528 | 1.1 | 11.304 |
Cephalosporins | 45 | 13 (50) | 32 (43.2) | 0.55 | 1.313 | 0.536 | 3.125 |
Aminoglycosides | 11 | 6 (23.1) | 5 (6.8) | 0.032 | 4.14 | 1.143 | 14.994 |
Augmentin | 5 | 1 (3.8) | 4 (5.4) | 0.75 | 0.700 | 0.075 | 6.565 |
Fluoroqinolones | 9 | 3 (11.5) | 6 (8.1) | 0.59 | 1.478 | 0.342 | 6.393 |
Interventions used | |||||||
Central venous line | 35 | 12 (46.2) | 23 (31.1) | 0.16 | 1.901 | 0.761 | 4.744 |
Ventilator | 61 | 21 (80.8) | 40 (54.1) | 0.01 | 3.570 | 1.216 | 10.483 |
Peripheral catheter | 83 | 22 (84.6) | 61 (82.4) | 0.79 | 1.172 | 0.345 | 3.978 |
Naso-gastric tube | 43 | 15 (57.7) | 28 (37.8) | 0.07 | 2.240 | 0.903 | 5.559 |
Oxygen Mask | 21 | 6 (23.1) | 15 (20.3) | 0.7 | 1.180 | 0.403 | 3.454 |
Co-morbid conditions | |||||||
Surgery | 15 | 7 (26.9) | 8 (10.8) | 0.048 | 3.039 | 0.976 | 9.461 |
Chronic lung disease | 20 | 2 (7.7) | 18 (24.3) | 0.06 | 0.259 | 0.056 | 1.206 |
Neoplasia | 7 | 1 (3.8) | 6 (8.1) | 0.4 | 0.453 | 0.052 | 3.955 |
Multivariate analysis | |||||||
Ventilator | 0.027 | 0.291 | 0.097 | 0.871 | |||
Aminoglycosides | 0.046 | 0.257 | 0.068 | 0.975 |